PB
Prolevi Bio develops a modified release thyroid hormone formulation that mimics the circadian rhythm to address the limitations of current treatments for hypothyroidism, which often fail to align with the body's natural hormone release cycles. This approach aims to enhance patient compliance, reduce long-term side effects, and improve overall treatment efficacy for the 80% of patients dissatisfied with existing therapies.
Updated 4 months ago
Funding
$6.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Prolevi Bio develops a modified release thyroid hormone formulation that mimics the circadian rhythm to address the limitations of current treatments for hypothyroidism, which often fail to align with the body's natural hormone release cycles. This approach aims to enhance patient compliance, reduce long-term side effects, and improve overall treatment efficacy for the 80% of patients dissatisfied with existing therapies.